Enfusion

Enfusion Interest Expense

Delisted

The Interest Expense of Enfusion (ENFN) as of Nov 7, 2026 is 1.69 M USD. In the previous year, Interest Expense was 1.64 M USD — a change of 3.17% (higher).

Interest Expense

1.69 MUSD

YoY

3.17%

Last updated:

Interest Expense of Enfusion is 2024 1.69 M USD. Interest Expense of Enfusion was 2023 1.64 M USD. It decreases by 3.17% higher compared to the previous year.

The Enfusion Interest Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Expense
Date
Interest Expense
Jan 1, 2019
-700,000.00 USD
Jan 1, 2020
-1.70 M USD
Jan 1, 2021
-4.60 M USD
Jan 1, 2022
400,000.00 USD
Jan 1, 2023
1.64 M USD
Jan 1, 2024
1.69 M USD
The Enfusion Interest Expense history
YEARInterest ExpenseYoY
1.69 MUSD+3.17%
1.64 MUSD+310.25%
400,000.00USD-108.70%
-4.60 MUSD+170.59%
-1.70 MUSD+142.86%
-700,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enfusion stock

Interest Expense of Enfusion is 1.69 M USD in 2024.

Interest Expense of Enfusion changed from 1.64 M USD to 1.69 M USD, representing a 3.17% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense Enfusion since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's Enfusion historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Enfusion

All Key Metrics — Enfusion